E-LIB Suche - Ergebnisse für: Vermersch, P

1

PCR66 Psychometric Validation of PROMIS-Fatigue-MS-8a Quest..:

Vermersch, P. ; Giovannoni, G. ; Arnould, B....
Value in Health. 26 (2023) 12 - p. S461 , 2023

Link: https://doi.org/10.1016/..

2

PCR122 Psychometric Evaluation of Multiple Sclerosis Impact..:

Giovannoni, G. ; Vermersch, P. ; Arnould, B....
Value in Health. 26 (2023) 12 - p. S472 , 2023

Link: https://doi.org/10.1016/..

3

NUTRISEP: Assessment of the nutritional status of patients ..:

Donzé, C. ; Massot, C. ; Defer, G....
Revue Neurologique. 179 (2023) 4 - p. 282-288 , 2023

Link: https://doi.org/10.1016/..

4

Secondary progressive multiple sclerosis: A national consen..:

Ciron, J. ; Gueguen, A. ; Al Khedr, A....
Revue Neurologique. 178 (2022) 10 - p. 1098-1104 , 2022

Link: https://doi.org/10.1016/..

5

Characterization of alexithymia in clinically isolated synd..:

Jougleux, C. ; Hennion, S. ; Outteryck, O...
Revue Neurologique. 177 (2021) 9 - p. 1145-1150 , 2021

Link: https://doi.org/10.1016/..

6

P34 Ocrelizumab treatment satisfaction in patients with sub..:

Van Wijmeersch, B. ; Buffels, R. ; Clinch, S....
Clinical Neurophysiology. 131 (2020) 4 - p. e195-e196 , 2020

Link: https://doi.org/10.1016/..

7

Efficacy and safety of ocrelizumab in patients with relapsi..:

Vermersch, P. ; Eralinna, J.P. ; Nicholas, R....
Journal of the Neurological Sciences. 405 (2019) - p. 310 , 2019

Link: https://doi.org/10.1016/..

8

Efficacy of cladribine tablets 3.5 mg/kg in patients with r..:

Giovannoni, G. ; Rammohan, K. ; Cook, S....
Journal of the Neurological Sciences. 405 (2019) - p. 177-178 , 2019

Link: https://doi.org/10.1016/..

9

Long-term disease stability assessed by the expanded disabi..:

Giovannoni, G. ; Comi, G. ; Rammohan, K....
Journal of the Neurological Sciences. 405 (2019) - p. 43 , 2019

Link: https://doi.org/10.1016/..

10

Reduction of risk of secondary progressive multiple scleros..:

Vermersch, P. ; Giovannoni, G. ; Soelberg-Sorensen, P....
Journal of the Neurological Sciences. 405 (2019) - p. 328 , 2019

Link: https://doi.org/10.1016/..

11

Inaugural tumor-like multiple sclerosis: clinical presentat..:

On behalf of the Société Francophone de la Sclérose en Plaques ; Balloy, G. ; Pelletier, J....
Journal of Neurology. 265 (2018) 10 - p. 2251-2259 , 2018

Link: https://doi.org/10.1007/..

12

Survey of diagnostic and treatment practices for multiple s..:

Fernández, O. ; Delvecchio, M. ; Edan, G....
European Journal of Neurology. 25 (2018) 5 - p. 739-746 , 2018

Link: https://doi.org/10.1111/..

13

Acute polyradiculopathy secondary to idelalisib in Relapsed..:

Barbieux, S. ; Boyle, E.M. ; Baillet, C....
Current Research in Translational Medicine. 66 (2018) 3 - p. 87-89 , 2018

Link: https://doi.org/10.1016/..

14

Clinical Efficacy Is Sustained in Relapsing Remitting Multi..:

Vermersch, P. ; Giovannoni, G. ; Soelberg-sorensen, P...
Multiple Sclerosis and Related Disorders. 26 (2018) - p. 260 , 2018

Link: https://doi.org/10.1016/..

15

P.027 Efficacy of a fourth alemtuzumab course in RRMS patie..:

Traboulsee, A ; Alroughani, R ; Boster, A...
Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. 45 (2018) s2 - p. S23-S23 , 2018

Link: https://doi.org/10.1017/..